Molecular Imaging Clinic
Providers can order PET/CT, CT, PET/MR, and MR scans at BAMF Health’s Molecular Imaging Clinic.
The uExplorer® Total-Body PET/CT is capable of scanning the total body in less than five minutes, improves the patient experience, and potentially eliminates claustrophobia. Capable of any PET/CT Study, including FDG, PSMA, Ga68-Dotatate.
The uPMR 790 3T PET/MR can acquire hybrid images while significantly reducing radiation exposure. Capable of any PET/MR study, especially tumor imaging of the brain, head and neck, and other indications in neurology and cardiology.
BAMF Health can capture images that could change staging or avoid unnecessary procedures
Order Form Downloads
- PET/CT Imaging (202KB PDF)
- PET/MR Imaging (216KB PDF)
- CT Imaging (195KB PDF)
- MR Imaging (212KB PDF)
Molecular Therapy Clinic
Providers can refer patients for molecular targeted therapy at BAMF Health’s Molecular Therapy Clinic.
Pluvicto® (Lu-177-PSMA-617) is indicated for metastatic castration resistant prostate cancer post hormone therapy and taxane-based chemotherapy.
Lutathera® (Lu-177-DOTATATE) is indicated for treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NET).
Patients receive post-therapy dosimetry using world’s most advanced digital SPECT/CT, GE StarGuide™.
Advanced Clinical Trials
BAMF Health is enrolling patients in multiple clinical trials for various cancers and diseases.
Please check back frequently as new and future trials will be added.